The U.S. unit of Lupin Ltd., an Indian drug maker, is recalling thousands of bottles of antibacterial drugs, due to a failure to meet the FDA standards for impurities. The recall, reported by the Wall Street Journal, was initiated on Jan. 27, but the FDA did not notify the public until the week of April 14.
This recall is for a drug called cefixime, which is an antibiotic used to treat bacterial infections of the upper-respiratory tract and of the ear. The FDA considers this a Class III recall, according to Reuters, meaning that use of or exposure to the drug is unlikely to cause adverse health effects.
Cohen Placitella & Roth PC has distinguished itself as proven leaders in product liability and consumer protection litigation, and has won multi-million dollar recoveries in a variety of these suits. We invite you to contact Chris Placitella, Esq. today for a consultation at 888-375-7600 to discuss your case.